Apoptosis in Oesophageal Adenocarcinoma
Author Information
Author(s): Raouf A, Evoy D, Carton E, Mulligan E, Griffin M, Sweeney E, Reynolds J V
Primary Institution: Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland
Hypothesis
Understanding molecular factors predicting response or resistance to chemoradiotherapy is necessary to enhance treatment results.
Conclusion
The study found that pre-operative chemoradiotherapy significantly increased apoptosis and decreased cell proliferation in oesophageal adenocarcinoma patients.
Supporting Evidence
- Apoptosis occurs among viable tumour cells in all adenocarcinoma cases examined.
- Pre-operative chemoradiotherapy significantly increased apoptosis.
- Pre-operative chemoradiotherapy significantly decreased cell proliferation as estimated by Ki-67 expression.
- Immunohistochemically detected p53 and bcl-2 gene products had no regulatory role in the apoptotic process.
- Cumulative expression of p53 protein is significantly associated with increasing proliferation activity.
Takeaway
This study looked at how cancer cells die and grow in patients with a specific type of cancer, showing that treatment can help more cells die and fewer cells grow.
Methodology
The study focused on apoptotic indices and cell-cycle related protein expression in patients with primary oesophageal adenocarcinoma.
Participant Demographics
Patients with primary oesophageal adenocarcinoma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website